Alternating developmental temperature within the viable range 13–33 °C, with increasing amplitude around a mean value of 23 °C but constant period (2 days, a 1 day/1 day rhythm), resulted in increased duration of development, decreased body weight and decreased growth rate of both male and female flies. Life span of female flies also decreased with increasing amplitude of temperature of oscillation but that of males increased (compared to that at the mean temperature) at moderate temperature amplitude. Variation of the period of oscillation (from a rhythm of 6 h/6 h up to 2 days/2 days) with constant amplitude (23 ± 5 °C), on the other hand, did not affect either duration of development or body weight of the flies. However, life span of the females only was unaffected but that of males was increased (above that at mean constant temperature 23 °C) at the fast oscillation patterns (6 h/6 h and 1 day/1 day). Finally, life span of both sexes was positively correlated with growth rate in the constant period/varying amplitude case, whereas in previous studies variation of growth rate in the same range by other means showed a biphasic or an invariant pattern of life span dependence on growth rate. These results are in agreement with the hypothesis of epigenetic influence on life span by alternating developmental temperature and corroborate the previous conclusion that growth rate per se does not determine life span.

Keywords:
Developmental temperature, alternating, Oscillation amplitude, varying, Oscillation period, varying, Drosophila melanogaster, Growth rate, Life span
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.